Stone Island Holdings Ltd – Trademark Portfolio

Entity Type: 03

Stone Island Holdings Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ALLIMED. The owner is based in East Sussex.

East Sussex TN317NY , GB

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ALLIMED
ALLIMED
Registered 2010

Trademark Classifications

Stone Island Holdings Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Stone Island Holdings Ltd have?

Stone Island Holdings Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Stone Island Holdings Ltd file in?

Stone Island Holdings Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Stone Island Holdings Ltd's most well-known trademarks?

Stone Island Holdings Ltd's registered trademark portfolio includes well-known marks such as ALLIMED. These are among 1 currently registered trademark in the portfolio.

What is Stone Island Holdings Ltd's trademark registration success rate?

Stone Island Holdings Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.